Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. Co. offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. Co. has offices in Switzerland, France and the United Kingdom and operates worldwide. We show 2 historical shares outstanding datapoints in our SOPH shares outstanding history coverage, used to compute SOPH market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SOPH market cap history over the course of time is important for investors
interested in comparing SOPH's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SOPH versus a peer is one thing; comparing
SOPH market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SOPH can fluctuate over the course of history.
With this page we aim to empower investors researching SOPH by allowing them to research the SOPH market cap history. |
Free SOPH Email Alerts:
Video: The Importance of Market Cap
